Browsing: Skin

Alopecia: All You Need To Know

By Tony ZhangApril 25, 20220

This year’s Oscar was nothing but full of drama. Chris Rock, the comedian and host for the event, made jokes…

Burns: Classifications and Emergency Treatments

By Tristenne OcampoApril 11, 20221

The skin is the largest organ of the body and it is the first line of defense against bacteria and…

The Newest JAK inhibitor for Psoriatic Arthritis: Upadacitinib (Rinvoq)

By KayeApril 7, 20220

HSA approves the first JAK inhibitor for moderate-to-severe atopic dermatitis: baricitinib (Olumiant)

By KayeFebruary 17, 20220

Atopic dermatitis can disrupt sleep, work, and daily life for many adults. New treatments like the JAK inhibitor baricitinib are reshaping care, with clinical trials showing promising results for patients with moderate-to-severe disease.

10 Skincare Tips by Dr Meg Sison, Dermatologist from the Philippines

By Sian LinFebruary 3, 20220

Always wondering what are the best skincare tips to keep your skin youthful-looking? What are the most crucial steps in…

The growing biologic armamentarium of plaque psoriasis treatment: A review of risankizumab (Skyrizi)

By KayeJanuary 20, 20220

Psoriasis can affect far more than the skin. New biologics like risankizumab target the IL-23 pathway, with trials showing high rates of skin clearance and sustained results for patients with moderate-to-severe plaque psoriasis.

Dandruff: Know Which Type Is Making Your Scalp Flaky and Itchy

By MCA TeamJanuary 13, 20220

Have you ever noticed white flakes on your shoulders and clothes that keep reappearing? Does your scalp itch uncontrollably that…

Ixekizumab (Taltz) for the Treatment of Plaque Psoriasis

By KayeJanuary 6, 20220

Psoriasis affects more than 40,000 people in Singapore and can lead to joint and cardiovascular complications. Clinical trials show the IL-17 inhibitor ixekizumab delivering strong skin clearance, shaping how moderate-to-severe psoriasis is treated.

IXORA trial: Comparison Between Ixekizumab and Guselkumab for Plaque Psoriasis

By Sian LinNovember 12, 20210

What are the differences in treatment effects between ixekizumab and guselkumab? Watch the IXORA trial summary video here.

Allergies: How Do You Recognise Them?

By Vicky LaiOctober 22, 20210

Allergies affect up to 20 percent of the world’s population. The severity of allergies varies amongst individuals and can range…

Copyright © Medical Channel Asia 2024. All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.

What's Hot

Is Your Partner’s Phone the Third Wheel?

“I Still Train, Work, Laugh”: Breast Cancer At 30

How Everyday Chemicals Are Impersonating Human Hormones

Browsing: Skin

Alopecia: All You Need To Know

Burns: Classifications and Emergency Treatments

The Newest JAK inhibitor for Psoriatic Arthritis: Upadacitinib (Rinvoq)

HSA approves the first JAK inhibitor for moderate-to-severe atopic dermatitis: baricitinib (Olumiant)

10 Skincare Tips by Dr Meg Sison, Dermatologist from the Philippines

The growing biologic armamentarium of plaque psoriasis treatment: A review of risankizumab (Skyrizi)

Dandruff: Know Which Type Is Making Your Scalp Flaky and Itchy

Ixekizumab (Taltz) for the Treatment of Plaque Psoriasis

IXORA trial: Comparison Between Ixekizumab and Guselkumab for Plaque Psoriasis

Allergies: How Do You Recognise Them?

Is Your Partner’s Phone the Third Wheel?

“I Still Train, Work, Laugh”: Breast Cancer At 30

How Everyday Chemicals Are Impersonating Human Hormones

Can You Stop a Migraine Before It Starts?

Subscribe to Updates

What's Hot

Browsing: Skin

Subscribe to Updates